P-1104

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameP-1104
Drug Alias NamePEG-INF (PharmaEssentia)PEGylated-interferon-beta (PharmaEssentia)P-1104
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaEssentia Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaEssentia Corp
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A